Child mental health

Understanding the Black Box Warning on Antidepressants for Youth

Save

The antidepressant black box warning is the FDA's strongest caution, flagging a small, early increased risk of suicidal thoughts in children, teens, and young adults. It is a call for close monitoring, not for avoiding treatment — untreated depression carries its own serious risks, and these medications help many young people. Follow-up visits are how the benefit comes safely.

Last updated: July 2026History

Talk to a clinician

A behavioral-health clinician

Gale can help you find one in your state and request a visit.

Find care →

What a "black box warning" actually is

A black box warning (boxed warning) is the most serious caution the FDA places on a prescription medication. It doesn't mean a medication is banned or that harm is likely — it means there's a specific risk important enough that prescribers and families should be clearly informed. For antidepressants, the boxed warning concerns a small increase in reports of suicidal thoughts and behaviors in people under 25, concentrated early in treatment.2

Why the warning exists — and what it doesn't say

The warning is based on analyses showing a small rise in suicidal thinking (not completed suicide) among youth starting antidepressants, mostly in the first weeks. It's a real signal worth respecting. What the warning does not say is that your child shouldn't take the medication: untreated depression is itself a major risk factor for suicidal thinking, and antidepressants help many young people recover. The warning's purpose is to make sure that benefit comes with careful watching, not to scare families away from effective treatment.

What close monitoring looks like

In practice, the warning translates into a plan: more frequent check-ins in the first weeks and after any dose change, clear instructions on what to watch for, and an open line to the prescriber. You and your teen are key observers — noticing new agitation, sleeplessness, withdrawal, or talk of hopelessness and reporting it promptly. Steady, supportive relationships at home are protective during this window, buffering stress while the medication takes effect 1. Pairing medication with therapy adds another layer of support and monitoring.

When your child's antidepressant needs a clinician

This is exactly the situation where an engaged clinician matters most. First, they confirm the diagnosis and weigh the real risks of untreated depression against the medication's risks, so the decision is informed rather than fearful. Second, they set up the close monitoring the warning calls for — early, frequent follow-up and a clear safety plan you can act on. Third, they often pair the medication with evidence-based therapy like CBT, which both treats the depression and adds eyes on your teen's mood. Fourth, they coordinate care across home and school and adjust quickly if something concerning shows up. The warning isn't a reason to go it alone — it's a reason to stay closely connected to a clinician.

Common questions

No. It flags a small, early increased risk of suicidal thoughts in youth and signals the need for close monitoring. For many young people the medication helps, and untreated depression carries its own serious risks. Your clinician weighs this with you.

Don't stop it on your own — abruptly stopping can cause its own problems. If you're worried, contact the prescriber promptly to discuss it. The warning calls for monitoring, not automatic discontinuation.

New or worsening agitation, sleeplessness, withdrawal, irritability, or any talk of hopelessness or self-harm. Report these to the prescriber right away, and seek emergency help if there's immediate danger.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

If things feel heavy, a person is available anytime — call or text 988.

Talk to a clinician

A behavioral-health clinician

Gale can help you find one in your state and request a visit.

Find care →

When to act now

  • —Any talk of suicide, self-harm, or not wanting to be alive
  • —New or sharply worsening agitation, restlessness, or impulsivity
  • —Sudden withdrawal, hopelessness, or dramatic mood changes after starting or changing the medication
  • —Severe sleeplessness or new aggression in the early weeks of treatment

If your teen is in immediate danger or talking about suicide, call or text 988 (Suicide & Crisis Lifeline) or text HOME to 741741 (Crisis Text Line). Call 911 for a medical emergency.

This article is general education, not medical advice or a diagnosis. Don't start or stop your child's medication without the prescribing clinician.

Did this answer your question?

References

  1. 1.Garner A, Yogman M; Committee on Psychosocial Aspects of Child and Family Health, Section on Developmental and Behavioral Pediatrics, Council on Early Childhood (American Academy of Pediatrics) (2021). Preventing Childhood Toxic Stress: Partnering With Families and Communities to Promote Relational Health. Pediatrics, 148(2):e2021052582. doi:10.1542/peds.2021-052582 ✓Safe, stable, nurturing relationships buffer stress and are protective during a vulnerable treatment window.
  2. 2.U.S. National Library of Medicine, MedlinePlus (2025). Fluoxetine: MedlinePlus Drug Information. MedlinePlus (National Library of Medicine). link ✓MedlinePlus warns that antidepressants such as fluoxetine may increase the risk of suicidal thoughts and actions in children, teenagers, and young adults (less than 24 years of age), most likely in the first few months of treatment and when the dose is increased.

2 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library